Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting.
van Zyl GU, van Mens TE, McIlleron H, Zeier M, Nachega JB, Decloedt E, Malavazzi C, Smith P, Huang Y, van der Merwe L, Gandhi M, Maartens G.
van Zyl GU, et al. Among authors: decloedt e.
J Acquir Immune Defic Syndr. 2011 Apr;56(4):333-9. doi: 10.1097/QAI.0b013e31820dc0cc.
J Acquir Immune Defic Syndr. 2011.
PMID: 21239995
Free PMC article.